AbbVie and Sandoz resolve Humira biosimilar patent disputes
DrugName : adalimumab AbbVie, a research-based global biopharmaceutical company, announced a global resolution of all intellectual property-related litigation with Sandoz
Read More
DrugName : adalimumab AbbVie, a research-based global biopharmaceutical company, announced a global resolution of all intellectual property-related litigation with Sandoz
Read MoreGeneva, September 25, 2018 PR/2018/821 Released jointly by WIPO and IFPMA WIPO and the research-based pharmaceutical industry today launched a
Read MoreCreated Date: October 2018 DRFCode: GDHC2053EI Could US Biosimilars Stakeholders Benefit from Certain Initiatives Similar to Those Offered In Emerging
Read MoreMonday, October 15, 2018 This is perhaps viagra soft tablet the main reason why impotence erectile dysfunction is Kamagra Jelly.
Read MoreEmergex Vaccines Holding Ltd., a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious
Read More